Insulet (PODD) Enterprise Value Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Insulet | 10.37 Bn | 9.89 Bn | 529.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.79% |
| Dec 31, 2025 | 5.45% |
| Sep 30, 2025 | 3.32% |
| Jun 30, 2025 | -5.84% |
| Mar 31, 2025 | -31.88% |
| Dec 31, 2024 | -20.45% |
| Sep 30, 2024 | -8.31% |
| Jun 30, 2024 | -21.53% |
| Mar 31, 2024 | -18.88% |
| Dec 31, 2023 | -19.51% |
| Sep 30, 2023 | -19.32% |
| Jun 30, 2023 | -17.64% |
| Mar 31, 2023 | -12.01% |
| Dec 31, 2022 | -8.94% |
| Sep 30, 2022 | -21.24% |
| Jun 30, 2022 | -22.38% |
| Mar 31, 2022 | -22.85% |
| Dec 31, 2021 | -21.58% |
| Sep 30, 2021 | -24.84% |
| Jun 30, 2021 | -50.95% |
| Mar 31, 2021 | -50.09% |
| Dec 31, 2020 | -50.51% |
| Sep 30, 2020 | -43.87% |
| Jun 30, 2020 | -42.22% |
| Mar 31, 2020 | -17.17% |
| Dec 31, 2019 | -19.99% |
| Sep 30, 2019 | -32.84% |
| Jun 30, 2019 | -12.03% |
| Mar 31, 2019 | -16.67% |
| Dec 31, 2018 | -14.05% |
| Sep 30, 2018 | -13.50% |
| Jun 30, 2018 | -14.71% |
| Mar 31, 2018 | -18.91% |
| Dec 31, 2017 | -50.34% |
| Sep 30, 2017 | -34.16% |
| Jun 30, 2017 | -29.82% |
| Mar 31, 2017 | -25.07% |
| Dec 31, 2016 | -26.02% |
| Sep 30, 2016 | -22.18% |
| Jun 30, 2016 | -0.83% |
| Mar 31, 2016 | -1.33% |
| Dec 31, 2015 | -1.61% |
| Sep 30, 2015 | -6.96% |
| Jun 30, 2015 | -4.21% |